Australian & New Zealand Childrens Haematology/Oncology Group
Study Title
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Protocol ID
ALTE15N2
Disease (Sub Disease)
Recurrent Neuroblastoma
Diagnosis Stage
Relapse/refractory
Location
WA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
Perth Children's Hospital
Starship Hospital
Starship Hospital
Study Type
Late Effects
Phase
Not applicable
Age Eligibility
5 Years to 50 Years
International registry ID's
NCT03057626
| Study Title | LEAHRN (Late Effects After High-Risk Neuroblastoma) Study |
|---|---|
| Protocol ID | ALTE15N2 |
| Disease (Sub Disease) | Recurrent Neuroblastoma |
| Diagnosis Stage | Relapse/refractory |
| Location | WA / NZ |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT03057626 |
| Trial Status | Open |
| Trial Open Date | 05/06/2017 |
| Sites | Perth Children's Hospital / Starship Hospital |
| Study Type | Late Effects |
| Phase | Not applicable |
| Age Eligibility | 5 Years to 50 Years |
| International registry ID's | NCT03057626 |